CFO appointment
Actinium Pharmaceuticals, Inc. appoints Matt David, M.D. as CFO
Actinium Pharmaceuticals, Inc. reported in a Form 8-K filed October 15, 2026 that Matt David, M.D. was appointed Chief Financial Officer and principal financial officer, effective October 14, 2026.
In the filing's words
On October 14, 2026, Matt David, M.D., age 49, commenced service as Chief Financial Officer and principal financial officer of Actinium Pharmaceuticals, Inc. (the “Company”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Actinium Pharmaceuticals, Inc. (ATNM) |
|---|---|
| Event | Appointment |
| Incoming | Matt David, M.D. |
| Title in the filing | Chief Financial Officer and principal financial officer |
| Effective | October 14, 2026 |
| 8-K filed | October 15, 2026 |
| Internal promotion | Not established by the source |
| SEC CIK | 0001388320 |
Actinium Pharmaceuticals, Inc. reported this change in a Form 8-K, Item 5.02, filed October 15, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-10-16
Something wrong about Matt David, M.D.? Send a correction with the primary source.